Octant Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 69

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $4.9M

  • Investors
  • 26

Octant General Information

Description

Developer of synthetic technology designed to improve health and treat disease. The company's platform uses synthetic biology, genome engineering, sequencing, and computational tools to simultaneously measure the activity of thousands of receptor pathways in human cells, enabling scientists to apply machine learning methods to engineer small molecules that interact with multiple receptors and unlock ways to treat complex diseases.

Contact Information

Website
www.octant.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 6701 Hollis Street
  • Emeryville, CA 94608
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 6701 Hollis Street
  • Emeryville, CA 94608
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Octant Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Grant 11-Jun-2025 $4.9M Completed Clinical Trials - Phase 1
6. Secondary Transaction - Private Completed Clinical Trials - Phase 1
5. Later Stage VC (Series B) 28-Apr-2022 Completed Clinical Trials - Phase 1
4. Early Stage VC (Series A) 20-May-2020 Completed Clinical Trials - Phase 1
3. Accelerator/Incubator 01-Jan-2019 Completed Clinical Trials - Phase 1
2. Early Stage VC (Series A) 01-Jan-2018 $4.94M $5.69M Completed Clinical Trials - Phase 1
1. Accelerator/Incubator $750K $750K Completed Clinical Trials - Phase 1
To view Octant’s complete valuation and funding history, request access »

Octant Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A-1
Series A 8,649,153 $0.000010 $0.21 $3.47 $3.47 1x $3.47 24.34%
To view Octant’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Octant Patents

Octant Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-12697327-B2 Pharmacological correctors of rhodopsin and uses thereof Active 28-Oct-2024
US-20260115174-A1 Pharmacological correctors of rhodopsin and uses thereof Active 28-Oct-2024
US-20260345564-A1 Pharmacological correctors of rhodopsin and uses thereof Pending 28-Oct-2024
WO-2026096386-A1 Pharmacological correctors of rhodopsin and uses thereof Pending 28-Oct-2024
WO-2026039421-A1 Nanoscale high-throughput chemistry screen Pending 13-Aug-2024 C40B50/08
To view Octant’s complete patent history, request access »

Octant Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Octant Investors (26)

Investor Name Investor Type Holding Investor Since Participating Rounds
Gates Foundation Not-For-Profit Venture Capital
10X Capital Venture Capital Minority
Bioverge Venture Capital Minority
Bristol-Myers Squibb Corporation Minority
Carbon Silicon Ventures Venture Capital Minority
You’re viewing 5 of 26 investors. Get the full list »

Octant FAQs

  • When was Octant founded?

    Octant was founded in 2017.

  • Where is Octant headquartered?

    Octant is headquartered in Emeryville, CA.

  • What is the size of Octant?

    Octant has 69 total employees.

  • What industry is Octant in?

    Octant’s primary industry is Drug Discovery.

  • Is Octant a private or public company?

    Octant is a Private company.

  • What is Octant’s current revenue?

    The current revenue for Octant is .

  • How much funding has Octant raised over time?

    Octant has raised $116M.

  • Who are Octant’s investors?

    Gates Foundation, 10X Capital, Bioverge, Bristol-Myers Squibb, and Carbon Silicon Ventures are 5 of 26 investors who have invested in Octant.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process